Immunostimulation in sepsis.
With the purpose of a practical synthesis the Authors consider their personal experience and an overview of the international literature on the topic, making a point of the actual knowledge on stimulation to treat the sepsis. Therefore their study take in account the characteristics of the human immune system and the peculiarities of the immunostimulating drugs today at hand, going down to practical employment of the last therapeutical applications.
Percopo
V
V
1st Department of Surgery, Medical School, University Federico II, Naples--Italy.
Taddeo
F
F
Cobellis
L
L
Tesauro
B
B
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D006801:Humans; D007114:Immunization; D007369:Interferon Inducers / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D016305:Thymopentin / Q000627:therapeutic use; D013949:Thymus Extracts / Q000627:therapeutic use; D014165:Transfer Factor / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D007369:Interferon Inducers; D013949:Thymus Extracts; D014165:Transfer Factor; C031407:thymostimulin; D007372:Interferons; C051006:thymomodulin; D016305:Thymopentin